Multiple Myelomas News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Multiple Myeloma: Upfront Therapy and Longer Remissions - OncLive - OncLive



OncLive
 
Multiple Myeloma: Upfront Therapy and Longer Remissions - OncLive 
OncLive
Thomas G. Martin, MD, and Gareth Morgan, MD, PhD, share their perspectives on the frontline treatment of multiple myeloma, including considerations for transplant eligibility and QUAD therapy.

and more » 


Haematological cancer: Daratumumab proves effective in patients with newly diagnosed multiple myeloma - Nature.com



Haematological cancer: Daratumumab proves effective in patients with newly diagnosed multiple myeloma 
Nature.com
A total of 706 patients with newly diagnosed multiple myeloma were randomly assigned to receive bortezomib plus melphalan and prednisone, with or without daratumumab. The overall response rate was 90.9% in the daratumumab group versus 73.9% in the ...

and more » 


Emerging Therapies Generate Excitement in Myeloma - OncLive



OncLive
 
Emerging Therapies Generate Excitement in Myeloma 
OncLive
In an interview during the 2017 OncLive State of the Science SummitTM on Hematologic Malignancies, Thomas G. Martin, MD, clinical professor of medicine, Adult Leukemia and Bone Marrow Transplantation Program, associate director of the Myeloma Program ...

 


Landgren Discusses Treatment Options in 2 Cases of Multiple Myeloma - Targeted Oncology



Targeted Oncology
 
Landgren Discusses Treatment Options in 2 Cases of Multiple Myeloma 
Targeted Oncology
Landgren: This is a relatively young individual who is diagnosed with multiple myeloma. FISH testing [was] conducted [which showed] a translocation. Because it is a relatively young patient who has multiple myeloma, and she has this 4;14 translocation ...

 


J&J's Darzalex wins limited NICE approval for multiple myeloma - FiercePharma



FiercePharma
 
J&J's Darzalex wins limited NICE approval for multiple myeloma 
FiercePharma
J&J's Darzalex wins limited NICE approval for multiple myeloma. by Eric Palmer |. Jan 17, 2018 9:22am. Darzalex. England's NICE has decided that Johnson & Johnson's multiple myeloma Darzalex can be funded as a fourth-line treatment through the Cancer ...
Despite Clinical Efficacy, Only Certain Myeloma Treatments Are Cost-Effective Curetoday.com

all 2 news articles » 


Amgen publishes positive data from Kyprolis multiple myeloma study - Zenopa



Curetoday.com
 
Amgen publishes positive data from Kyprolis multiple myeloma study 
Zenopa
Amgen has announced the publication of new clinical trial data demonstrating the benefits of its cancer drug Kyprolis in the treatment of multiple myeloma. Published in the Journal of Clinical Oncology, the final analysis from the phase III ASPIRE ...
FDA Grants Approval to Carfilzomib Label Update in Myeloma Targeted Oncology
FDA Adds Overall Survival Data to Kyprolis Label Rare Disease Report
Kyprolis Label Update Approved for Myeloma Treatment Curetoday.com
Managed Care magazine  -Nasdaq  -Drug Discovery & Development 
all 11 news articles » 


FDA Approves Carfilzomib Label Update in Myeloma - OncLive - OncLive



FDA Approves Carfilzomib Label Update in Myeloma - OncLive 
OncLive
The FDA has approved a supplemental new drug application that adds overall survival data from the phase III ENDEAVOR trial to the label for carfilzomib for use in patients with relapsed or refractory multiple myeloma.

and more » 


Dr. Martin on Choosing Treatments for Multiple Myeloma - OncLive - OncLive



Dr. Martin on Choosing Treatments for Multiple Myeloma - OncLive 
OncLive
Thomas G. Martin, MD, clinical professor of medicine, Adult Leukemia and Bone Marrow Transplantation Program, and associate director, Myeloma Program, University of California, San Francisco; co-leader, Hematopoietic Malignancies Program, Helen Diller ...

and more » 


Dr. Richter on Study of Symptom Management in Multiple Myeloma - OncLive



OncLive
 
Dr. Richter on Study of Symptom Management in Multiple Myeloma 
OncLive
Joshua Richter, MD, a hematologist/oncologist specializing in multiple myeloma at the John Theurer Cancer Center discusses symptom management in patients with multiple myeloma. The management of multiple myeloma has advanced greatly in recent years ...

 


Amgen kicks off 2018 with double the good news for slow-growing Kyprolis - FiercePharma



FiercePharma
 
Amgen kicks off 2018 with double the good news for slow-growing Kyprolis 
FiercePharma
The way Amgen sees it, the label update supports the Kyprolis-dexamethasone combo's status as the only preferred two-drug regimen recommended by the National Comprehensive Cancer Network Clinical Practice Guidelines for relapsed multiple myeloma ...